The slip
PARKINSON RECEIPTno. 7403
23 Oct 2026, 09:23 UTCdopamine neurons, braak
predictionG3BP2 in dopamine neurons tracks Braak Lewy-body stage
registeredc17f2318820ec0db
discovery+0.11 p=0.785 n=9
replication-0.02 p=0.959 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.11, p 0.785)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT28896ce0765dc32ca8674579…
follows 543a533e329f…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7403: G3BP2 in dopamine neurons, braak
- power
- full sample -0.19 (p 0.450, n 18), 95% CI -0.60 to +0.30. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.32 (p 0.194, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.29 (p 0.250, n 18). could be the mix.
- skeptic
- leave-one-out range -0.33 to -0.09, sign flips 0; without severely affected donors -0.19 (p 0.450, n 18). fragile.
- cell type
- strongest in astrocytes: -0.59 (p 0.0096, n 18) vs -0.19 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for G3BP2 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up G3BP2 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.02 p 0.929 (needs p < 2.8e-4)